{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,5,10]],"date-time":"2023-05-10T08:27:05Z","timestamp":1683707225723},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2017,2,3]],"date-time":"2017-02-03T00:00:00Z","timestamp":1486080000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1007\/s00296-017-3654-0","type":"journal-article","created":{"date-parts":[[2017,2,3]],"date-time":"2017-02-03T12:27:45Z","timestamp":1486124865000},"page":"847-851","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Systemic sclerosis with anti-RNA polymerase III positivity following silicone breast implant rupture: possible role of B-cell depletion and implant removal in the treatment"],"prefix":"10.1007","volume":"37","author":[{"given":"Francesca","family":"Dall\u2019Ara","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria-Grazia","family":"Lazzaroni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiara M.","family":"Antonioli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paolo","family":"Air\u00f2","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,2,3]]},"reference":[{"key":"3654_CR1","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.jaut.2012.05.002","volume":"39","author":"FW Miller","year":"2012","unstructured":"Miller FW, Alfredsson L, Costenbader KH et al (2012) Epidemiology of environmental exposures and human autoimmune diseases: findings from a National Institute of Environmental Health Sciences Expert Panel Workshop. J Autoimmun 39:259\u2013271","journal-title":"J Autoimmun"},{"key":"3654_CR2","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.autrev.2013.10.002","volume":"13","author":"I Marie","year":"2014","unstructured":"Marie I, Gehanno JF, Bubenheim M et al (2014) Prospective study to evaluate the association between systemic sclerosis and occupational exposure and review of the literature. Autoimmun Rev 13:151\u2013156","journal-title":"Autoimmun Rev"},{"key":"3654_CR3","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1177\/0961203311430703","volume":"21","author":"M Lidar","year":"2012","unstructured":"Lidar M, Agmon-Levin N, Langevitz P, Shoenfeld Y (2012) Silicone and scleroderma revisited. Lupus 21:121\u2013127","journal-title":"Lupus"},{"key":"3654_CR4","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1056\/NEJM200003163421105","volume":"342","author":"EC Janowsky","year":"2000","unstructured":"Janowsky EC, Kupper LL, Hulka BS (2000) Meta-analyses of the relation between silicone breast implants and the risk of connective-tissue diseases. N Eng J Med 342:781\u2013790","journal-title":"N Eng J Med"},{"key":"3654_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.rdc.2007.12.001","volume":"34","author":"VD Steen","year":"2008","unstructured":"Steen VD (2008) The many faces of scleroderma. Rheum Dis Clin North Am 34:1\u201315","journal-title":"Rheum Dis Clin North Am"},{"key":"3654_CR6","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1111\/1346-8138.13292","volume":"43","author":"R Saigusa","year":"2016","unstructured":"Saigusa R, Asano Y, Nakamura K et al (2016) Association of anti-RNA polymerase III antibody and silicone breast implants in patients with systemic sclerosis. J Dermatol 43: 808\u2013810","journal-title":"J Dermatol"},{"key":"3654_CR7","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1002\/art.39501","volume":"68","author":"D Khanna","year":"2016","unstructured":"Khanna D, Berrocal VJ, Giannini EH et al (2016) The American College of Rheumatology provisional composite response index for clinical trials in early diffuse cutaneous systemic sclerosis. Arthritis Rheumatol 68:299\u2013311","journal-title":"Arthritis Rheumatol"},{"key":"3654_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/art.1780270101","volume":"27","author":"Y Kumagai","year":"1984","unstructured":"Kumagai Y, Shiokawa Y, Medsger TA Jr, Rodnan GP (1984) Clinical spectrum of connective tissue disease after cosmetic surgery. Observations on eighteen patients and a review of the Japanese literature. Arthritis Rheum 27:1\u201312","journal-title":"Arthritis Rheum"},{"key":"3654_CR9","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1136\/ard.43.3.520","volume":"43","author":"Y Okano","year":"1984","unstructured":"Okano Y, Nishikai M, Sato A (1984) Scleroderma, primary biliary cirrhosis, and Sjogren\u2019s syndrome after cosmetic breast augmentation with silicone injection: a case report of possible human adjuvant disease. Ann Rheum Dis 43:520\u2013522","journal-title":"Ann Rheum Dis"},{"key":"3654_CR10","doi-asserted-by":"publisher","first-page":"377","DOI":"10.7326\/0003-4819-111-5-377","volume":"111","author":"J Varga","year":"1989","unstructured":"Varga J, Schumacher HR, Jimenez SA (1989) Systemic sclerosis after augmentation mammoplasty with silicone implants. Ann Intern Med 111:377\u2013383","journal-title":"Ann Intern Med"},{"key":"3654_CR11","first-page":"958","volume":"20","author":"H Spiera","year":"1993","unstructured":"Spiera H, Kerr LD (1993) Scleroderma following silicone implantation: a cumulative experience of 11 cases. J Rheumatol 20:958\u2013961","journal-title":"J Rheumatol"},{"key":"3654_CR12","first-page":"225","volume":"160","author":"HN Claman","year":"1994","unstructured":"Claman HN, Robertson AD (1994) Antinuclear antibodies and breast implants. West J Med 160:225\u2013228","journal-title":"West J Med"},{"key":"3654_CR13","first-page":"1904","volume":"23","author":"CJ Burns","year":"1996","unstructured":"Burns CJ, Laing TJ, Gillespie BW et al (1996) The epidemiology of scleroderma among women: assessment of risk from exposure to silicone and silica. J Rheumatol 23:1904\u20131911","journal-title":"J Rheumatol"},{"key":"3654_CR14","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1111\/j.1445-5994.1996.tb01921.x","volume":"26","author":"H Englert","year":"1996","unstructured":"Englert H, Morris D, March L (1996) Scleroderma and silicone gel breast prostheses\u2014the Sydney study revisited. Aust N Z J Med 26:349\u2013355","journal-title":"Aust N Z J Med"},{"key":"3654_CR15","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1001\/jama.1996.03530320040032","volume":"275","author":"CH Hennekens","year":"1996","unstructured":"Hennekens CH, Lee I-M, Cook NR et al (1996) Self-reported breast implants and connective-tissue diseases in female health professionals: a retrospective cohort study. JAMA 275:616\u2013621 (Erratum, JAMA 1998 279:198)","journal-title":"JAMA"},{"key":"3654_CR16","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1002\/art.1780390708","volume":"39","author":"MC Hochberg","year":"1996","unstructured":"Hochberg MC, Perlmutter DL, Medsger TA Jr et al (1996) Lack of association between augmentation mammoplasty and systemic sclerosis (scleroderma). Arthritis Rheum 39:1125\u20131131","journal-title":"Arthritis Rheum"},{"key":"3654_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/00000637-199707000-00001","volume":"39","author":"S Friis","year":"1997","unstructured":"Friis S, Mellemkjaer L, McLaughlin JK et al (1997) Connective tissue disease and other rheumatic conditions following breast implants in Denmark. Ann Plast Surg 39:1\u20138","journal-title":"Ann Plast Surg"},{"key":"3654_CR18","first-page":"1854","volume":"24","author":"JV Lacey Jr","year":"1997","unstructured":"Lacey JV Jr, Laing TJ, Gillespie BW, Schottenfeld D (1997) Epidemiology of scleroderma among women: assessment of risk from exposure to silicone and silica. J Rheumatol 24:1854\u20131855","journal-title":"J Rheumatol"},{"key":"3654_CR19","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1177\/0961203309347795","volume":"18","author":"Y Levy","year":"2009","unstructured":"Levy Y, Rotman-Pikielny P, Ehrenfeld M, Shoenfeld Y (2009) Silicone breast implantation-induced scleroderma: description of four patients and a critical review of the literature. Lupus 18:1226\u20131232","journal-title":"Lupus"},{"key":"3654_CR20","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1684\/ejd.2013.2167","volume":"23","author":"S Motegi","year":"2013","unstructured":"Motegi S, Hattori T, Tago O, Shimizu A, Ishikawa O (2013) Systemic sclerosis associated with silicone breast implantation. Eur J Dermatol 23:894\u2013895","journal-title":"Eur J Dermatol"},{"key":"3654_CR21","first-page":"262","volume":"32","author":"G Al Aranji","year":"2014","unstructured":"Al Aranji G, White D, Solanki K (2014) Scleroderma renal crisis following silicone breast implant rupture: a case report and review of the literature. Clin Exp Rheumatol 32:262\u2013266","journal-title":"Clin Exp Rheumatol"},{"key":"3654_CR22","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/809629","author":"A Psarras","year":"2014","unstructured":"Psarras A, Gkougkourelas I, Tselios K, Sarantopoulos A, Boura P (2014) Systemic sclerosis and silicone breast implant: a case report and review of the literature. Case Rep Rheumatol. doi: 10.1155\/2014\/809629 (Epub 2014 Sep 30)","journal-title":"Case Rep Rheumatol"},{"key":"3654_CR23","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1093\/qjmed\/hcu156","volume":"108","author":"C Hong","year":"2015","unstructured":"Hong C, Sangle SR, Coghlan JG, D\u2019Cruz DP (2015) Scleroderma and breast implants. Q J Med 108:569\u2013570","journal-title":"Q J Med"},{"key":"3654_CR24","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.7326\/0003-4819-119-10-199311150-00007","volume":"119","author":"Y Okano","year":"1993","unstructured":"Okano Y, Steen VD, Medsger TA Jr (1993) Autoantibody reactive with RNA polymerase III in systemic sclerosis. Ann Intern Med 119:1005\u20131013","journal-title":"Ann Intern Med"},{"key":"3654_CR25","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/rheumatology\/37.1.15","volume":"37","author":"CC Bunn","year":"1998","unstructured":"Bunn CC, Denton CP, Shi-wen X, Knight C, Black CM (1998) Anti-RNA polymerases and other autoantibody specificities in systemic sclerosis. Br J Rheumatol 37:15\u201320","journal-title":"Br J Rheumatol"},{"key":"3654_CR26","doi-asserted-by":"publisher","first-page":"2742","DOI":"10.1002\/art.10521","volume":"46","author":"M Kuwana","year":"2002","unstructured":"Kuwana M, Kimura K, Kawakami Y (2002) Identification of an immunodominant epitope on RNA polymerase III recognized by systemic sclerosis sera: application to enzyme-linked immunosorbent assay. Arthritis Rheum 46:2742\u20132747","journal-title":"Arthritis Rheum"},{"key":"3654_CR27","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1016\/j.autrev.2009.02.002","volume":"8","author":"I Cavazzana","year":"2009","unstructured":"Cavazzana I, Ceribelli A, Air\u00f2 P, Zingarelli S, Tincani A, Franceschini F (2009) Anti-RNA polymerase III antibodies: a marker of systemic sclerosis with rapid onset and skin thickening progression. Autoimmun Rev 8:580\u2013584","journal-title":"Autoimmun Rev"},{"key":"3654_CR28","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.3899\/jrheum.100124","volume":"37","author":"A Ceribelli","year":"2010","unstructured":"Ceribelli A, Cavazzana I, Air\u00f2 P, Franceschini F (2010) Anti-RNA polymerase III antibodies as a risk marker for early gastric antral vascular ectasia (GAVE) in systemic sclerosis. J Rheumatol 37:1544","journal-title":"J Rheumatol"},{"key":"3654_CR29","doi-asserted-by":"publisher","first-page":"99","DOI":"10.3899\/jrheum.130386","volume":"41","author":"E Ghr\u00e9nassia","year":"2014","unstructured":"Ghr\u00e9nassia E, Avouac J, Khanna D et al (2014) Prevalence, correlates and outcomes of gastric antral vascular ectasia in systemic sclerosis: a EUSTAR case-control study. J Rheumatol 41:99\u2013105","journal-title":"J Rheumatol"},{"key":"3654_CR30","doi-asserted-by":"publisher","first-page":"2787","DOI":"10.1002\/art.27549","volume":"62","author":"AA Shah","year":"2010","unstructured":"Shah AA, Rosen A, Hummers L, Wigley F, Casciola-Rosen L (2010) Close temporal relationship between onset of cancer and scleroderma in patients with RNA polymerase I\/III antibodies. Arthritis Rheum 62:2787\u20132795","journal-title":"Arthritis Rheum"},{"key":"3654_CR31","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.3899\/jrheum.101144","volume":"38","author":"P Air\u00f2","year":"2011","unstructured":"Air\u00f2 P, Ceribelli A, Cavazzana I, Taraborelli M, Zingarelli S, Franceschini F (2011) Malignancies in Italian patients with systemic sclerosis positive for anti-RNA polymerase III antibodies. J Rheumatol 38:1329\u20131334","journal-title":"J Rheumatol"},{"key":"3654_CR32","doi-asserted-by":"publisher","first-page":"R211","DOI":"10.1186\/ar3544","volume":"13","author":"M Nikpour","year":"2011","unstructured":"Nikpour M, Hissaria P, Byron J et al (2011) Prevalence, correlates and clinical usefulness of antibodies to RNA polymerase III in systemic sclerosis: a cross-sectional analysis of data from an Australian cohort. Arthritis Res Ther 13:R211","journal-title":"Arthritis Res Ther"},{"key":"3654_CR33","doi-asserted-by":"publisher","first-page":"R53","DOI":"10.1186\/ar4486","volume":"16","author":"P Moinzadeh","year":"2014","unstructured":"Moinzadeh P, Fonseca C, Hellmich M et al (2014) Association of anti-RNA polymerase III autoantibodies and cancer in scleroderma. Arthritis Res Ther 16:R53","journal-title":"Arthritis Res Ther"},{"key":"3654_CR34","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1111\/1346-8138.12827","volume":"42","author":"R Saigusa","year":"2015","unstructured":"Saigusa R, Asano Y, Nakamura K et al (2015) Association of anti-RNA polymerase III antibody and malignancy in Japanese patients with systemic sclerosis. J Dermatol 42:524\u2013527","journal-title":"J Dermatol"},{"key":"3654_CR35","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1002\/art.39022","volume":"67","author":"AA Shah","year":"2015","unstructured":"Shah AA, Hummers LK, Casciola-Rosen L, Visvanathan K, Rosen A, Wigley FM (2015) Examination of autoantibody status and clinical features associated with cancer risk and cancer-associated scleroderma. Arthritis Rheumatol 67:1053\u20131061","journal-title":"Arthritis Rheumatol"},{"key":"3654_CR36","first-page":"33","volume":"1","author":"MG Lazzaroni","year":"2016","unstructured":"Lazzaroni MG, Cavazzana I, Dall\u2019Ara F et al (2016) Increased frequency of malignancies, and in particular breast cancer, synchronous to the onset of Systemic Sclerosis in anti-RNA Polymerase III antibodies positive patients: a EUSTAR multicentre study. J Scleroderma Relat Dis 1:33\u201334 (abstract)","journal-title":"J Scleroderma Relat Dis"},{"key":"3654_CR37","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1126\/science.1246886","volume":"343","author":"CG Joseph","year":"2014","unstructured":"Joseph CG, Darrah E, Shah AA et al (2014) Association of the autoimmune disease scleroderma with an immunologic response to cancer. Science 343:152\u2013157","journal-title":"Science"},{"key":"3654_CR38","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1177\/0961203309345724","volume":"18","author":"E Israeli","year":"2009","unstructured":"Israeli E, Agmon-Levin N, Blank M, Shoenfeld Y (2009) Adjuvants and autoimmunity. Lupus 18:1217\u20131225","journal-title":"Lupus"},{"key":"3654_CR39","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.1136\/annrheumdis-2015-208024","volume":"75","author":"R Dobrota","year":"2016","unstructured":"Dobrota R, Maurer B, Graf N et al (2016) Prediction of improvement in skin fibrosis in diffuse cutaneous systemic sclerosis: a EUSTAR analysis. Ann Rheum Dis 75:1743\u20131748","journal-title":"Ann Rheum Dis"},{"key":"3654_CR40","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/j.semarthrit.2014.09.002","volume":"44","author":"SL Bosello","year":"2015","unstructured":"Bosello SL, DeLuca G, Rucco M et al (2015) Long-term efficacy of B cell depletion therapy on lung and skin involvement in diffuse systemic sclerosis. Semin Arthritis Rheum 44:428\u2013436","journal-title":"Semin Arthritis Rheum"},{"key":"3654_CR41","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1002\/art.24249","volume":"60","author":"R Lafyatis","year":"2009","unstructured":"Lafyatis R, Kissin E, York M et al (2009) B cell depletion with rituximab in patients with diffuse cutaneous systemic sclerosis. Arthritis Rheum 60:578\u2013583","journal-title":"Arthritis Rheum"},{"key":"3654_CR42","doi-asserted-by":"publisher","first-page":"247","DOI":"10.3899\/jrheum.150105","volume":"43","author":"C Bonroy","year":"2016","unstructured":"Bonroy C, Smith V, Deschepper E, De Keyser F, Devreese K (2016) Specific antinuclear antibody level changes after B cell depletion therapy in systemic sclerosis are associated with improvement of skin thickening. J Rheumatol 43:247\u2013249","journal-title":"J Rheumatol"},{"key":"3654_CR43","first-page":"S17","volume":"30","author":"D Daoussis","year":"2012","unstructured":"Daoussis D, Liossis SC, Tsamandas AC et al (2012) Effect of long-term treatment with rituximab on pulmonary function and skin fibrosis in patients with diffuse systemic sclerosis. Clin Exp Rheumatol 30:S17\u2013S22","journal-title":"Clin Exp Rheumatol"},{"key":"3654_CR44","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1136\/annrheumdis-2013-204522","volume":"74","author":"S Jordan","year":"2015","unstructured":"Jordan S, Distler JH, Maurer B et al (2015) Effects and safety of rituximab in systemic sclerosis: an analysis from the European Scleroderma Trial and Research (EUSTAR) group. Ann Rheum Dis 74:1188\u20131194","journal-title":"Ann Rheum Dis"},{"key":"3654_CR45","doi-asserted-by":"publisher","first-page":"1943","DOI":"10.2174\/0929867322666150209161224","volume":"22","author":"T Dimitroulas","year":"2015","unstructured":"Dimitroulas T, Daoussis D, Garyfallos A, Sfikakis PP, Kitas GD (2015) Molecular and cellular pathways as treatment targets for biologic therapies in systemic sclerosis. Curr Med Chem 22:1943\u20131955","journal-title":"Curr Med Chem"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-017-3654-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00296-017-3654-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-017-3654-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T17:55:39Z","timestamp":1601574939000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00296-017-3654-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2,3]]},"references-count":45,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,5]]}},"alternative-id":["3654"],"URL":"https:\/\/doi.org\/10.1007\/s00296-017-3654-0","relation":{},"ISSN":["0172-8172","1437-160X"],"issn-type":[{"value":"0172-8172","type":"print"},{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2,3]]}}}